Molecular Nutrition & Food Research · 2019 · 50 citations · 37 references
MedicineNutritionNutritional SciencesAgingMolecular NeurobiologyMolecular NeuroscienceCognitive AgingCognitive DeclineCognitive ImpairmentMicrorna BiologyNeuroprotectionAdvanced Glycation End ProductsCognitive Decline PreventionDiet-responsive Micrornas
SCOPE: Dietary advanced glycation products (dAGEs) have been reported to induce cognitive impairment while quercetin possesses potential neuroprotective effects. The aim is to explore whether dAGEs would induce similar cognitive impairment from both young and aged ICR mice, and the protective effects of quercetin. METHODS AND RESULTS: A total of 32 aged ICR mice (15-month-old) and 16 young ICR mice (3-month-old) are randomly assigned into the following six groups: Young mice control group, young mice fed with AGEs diet group, old mice control group, old mice fed with AGEs diet group, old mice with quercetin supplemented diet group, old mice fed with AGE diet supplemented with quercetin group. Dietary AGEs induced cognitive impairment only in aged, but not in young, ICR mice, while quercetin intervention is capable of reversing dAGEs-induced cognitive dysfunction. This may be since quercetin 1) increased miR-219, miR-15a, and miR-132 expression, inhibited p-ERK1/2, and tau phosphorylation; and 2) improved gut microbiota richness and diversity, inhibited phylum Tenericutes and Proteobacteria, and elevated butyric acid from cecum. CONCLUSION: Prolonged application of quercetin may be beneficial in the elderly, especially for those with high consumption of dAGEs.
37
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Gentry N. Patrick, Lawrence Zukerberg, Margareta Nikolić et al. · Nature · 1999 · 1.5K citations
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Xiuying Zhang, Dongqian Shen, Zhiwei Fang et al. · PLoS ONE · 2013 · 966 citations · Full text
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J. During, Lei Cao, David S. Zuzga et al. · Nature Medicine · 2003 · 844 citations
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Alexandre Bejanin, Daniel R. Schonhaut, Renaud La Joie et al. · Brain · 2017 · 799 citations · Full text